These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6587365)

  • 1. Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.
    Adams DO; Hall T; Steplewski Z; Koprowski H
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3506-10. PubMed ID: 6587365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
    Herlyn D; Koprowski H
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4761-5. PubMed ID: 6289317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.
    Drebin JA; Link VC; Greene MI
    Oncogene; 1988 Apr; 2(4):387-94. PubMed ID: 2896329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
    Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
    J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody.
    Steplewski Z; Herlyn D; Maul G; Koprowski H
    Hybridoma; 1983; 2(1):1-5. PubMed ID: 6678794
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide.
    Steplewski Z; Lubeck MD; Scholz D; Loibner H; McDonald Smith J; Koprowski H
    In Vivo; 1991; 5(2):79-83. PubMed ID: 1768791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo destruction of canine lymphoma mediated by murine monoclonal antibodies.
    Steplewski Z; Rosales C; Jeglum KA; McDonald-Smith J
    In Vivo; 1990; 4(4):231-4. PubMed ID: 2103365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
    Steplewski Z; Sun LK; Shearman CW; Ghrayeb J; Daddona P; Koprowski H
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4852-6. PubMed ID: 3387441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.
    Herlyn D; Powe J; Ross AH; Herlyn M; Koprowski H
    J Immunol; 1985 Feb; 134(2):1300-4. PubMed ID: 3965572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cells.
    Larson LN; Johansson C; Lindholm L; Holmgren J
    Int J Cancer; 1988 Dec; 42(6):877-82. PubMed ID: 3192334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient selection of human tumor growth-inhibiting monoclonal antibodies.
    Herlyn D; Herlyn M; Ross AH; Ernst C; Atkinson B; Koprowski H
    J Immunol Methods; 1984 Oct; 73(1):157-67. PubMed ID: 6491298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct mechanisms of antitumor activity mediated by the combination of interleukin 2 and monoclonal antibodies.
    Vuist WM; van Buitenen F; Hekman A; Melief CJ
    Cancer Res; 1990 Sep; 50(18):5767-72. PubMed ID: 1697500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.
    Hellström I; Beaumier PL; Hellström KE
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7059-63. PubMed ID: 3462743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine monoclonal IgG antibodies: differences in their IgG isotypes can affect the antibody effector activity when using human cells.
    Lobo PI; Patel HC
    Immunol Cell Biol; 1997 Jun; 75(3):267-74. PubMed ID: 9243292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma.
    Basham TY; Kaminski MS; Kitamura K; Levy R; Merigan TC
    J Immunol; 1986 Nov; 137(9):3019-24. PubMed ID: 3760580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants.
    Steplewski Z; Spira G; Blaszczyk M; Lubeck MD; Radbruch A; Illges H; Herlyn D; Rajewsky K; Scharff M
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8653-7. PubMed ID: 2934735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.
    Dhein J; Daniel PT; Trauth BC; Oehm A; Möller P; Krammer PH
    J Immunol; 1992 Nov; 149(10):3166-73. PubMed ID: 1431095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.